Target intelligence / Profile preview

Bacterial cytoplasmic membrane phosphatidylglycerol-rich and cardiolipin-rich domains (PG/CL domains)

Target
PG/CL domains
Molecular classification
Membrane microdomain, Lipid domain, Anionic phospholipid cluster
01

Overview

Bacterial cytoplasmic membrane phosphatidylglycerol-rich and cardiolipin-rich domains are specialized lipid microdomains within the inner membrane of bacteria, primarily composed of the anionic phospholipids phosphatidylglycerol (PG) and cardiolipin (CL) (Weibel, 2011) [1.2.5]. These domains are typically localized at high-curvature regions such as the cell poles and the division septum, where they serve as essential scaffolds for organizing proteins involved in cell division, cell wall synthesis, and oxidative phosphorylation (Mingeot-Leclercq et al., 2017) [1.1.1]. Because of their critical role in bacterial physiology and their distinct composition compared to mammalian membranes, they are significant targets for antimicrobial therapy (Liu et al., 2024) [1.4.1]. Drugs like daptomycin exploit these domains by binding to PG in a calcium-dependent manner, causing lipid clustering and membrane depolarization (Taylor & Palmer, 2016) [1.3.3]. Other agents, such as amphiphilic aminoglycosides, target cardiolipin-rich domains to disrupt the respiratory chain and displace cytoskeleton-associated proteins like MreB (Mingeot-Leclercq et al., 2017) [1.2.1]. Resistance to such drugs often involves the remodeling of these domains, such as the conversion of PG to lysyl-PG or the redistribution of CL (Munita et al., 2016) [1.3.2]. Targeting these domains provides a pathway for developing antibiotics against multidrug-resistant pathogens like MRSA and Pseudomonas aeruginosa (Liu et al., 2025) [1.4.2].

Other names
Cardiolipin microdomainsPhosphatidylglycerol-rich domainsAnionic lipid microdomainsBacterial membrane raftsCL-rich domains
02

Mechanism of action

Drugs targeting these domains typically bind to anionic phospholipids like phosphatidylglycerol (PG) or cardiolipin (CL) in a concentration-dependent or calcium-dependent manner. For example, daptomycin binds PG to form daptomycin-PG clusters that depolarize the membrane (Taylor & Palmer, 2016) [1.3.3]. Other agents like 3',6-dinonyl neamine induce cardiolipin relocation, which disrupts the respiratory chain and displaces proteins like MreB (Mingeot-Leclercq et al., 2017) [1.1.1]. These interactions lead to the disruption of membrane biophysical properties, dissipation of the proton motive force, and metabolic disturbance, ultimately resulting in cell death (Liu et al., 2024) [1.4.1].

03

Biological functions

Cell divisionOxidative phosphorylationProtein localizationMembrane curvature sensingStress responseCell wall synthesis
04

Disease associations

Infection
05

Safety considerations

Potential cross-reactivity with mitochondrial cardiolipinDevelopment of resistance via lipid remodeling (e.g., MprF-mediated lysyl-PG synthesis)Alterations in membrane fluidity affecting host-cell interactions
06

Interacting drugs

Daptomycin

5 more in the full profile.

07

Biomarkers

Phosphatidylglycerol levelsCardiolipin levelsMembrane potentialProton motive forceBacterial cell morphology

Beyond the preview

Go deeper on Bacterial cytoplasmic membrane phosphatidylglycerol-rich and cardiolipin-rich domains (PG/CL domains).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cytoplasmic membrane phosphatidylglycerol-rich and cardiolipin-rich domains (PG/CL domains).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call